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Inhibitor of kappa B (IkB)-z, a member of the nuclear IkB family of proteins, is induced by the trans-
forming growth factor (TGF)-b signaling pathway and plays a pivotal role in maintaining the balance of T
helper (Th) cell subsets. IkB-z deﬁciency results in reduced percentages of Th17 cells and increased
percentages of Th1 cells. In this study, the effects of IkB-z deﬁciency on T-cell subsets were examined
further. The data showed that IkB-z-deﬁcient T cells had a high capacity for generation of regulatory T
cells (Tregs) when T cells were cultured under TGF-b stimulation in the presence of cytokine-
neutralizing antibodies. Mechanistically, IkB-z itself negatively regulated activation of the Foxp3 pro-
moter in a nuclear factor of kappaB-dependent manner. Thus, this study showed that IkB-z controlled
Treg differentiation.
© 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Inhibitor of kappaB (IkB)-z is a nuclear IkB family protein that is
upregulated in macrophages in response to lipopolysaccharide
(LPS) stimulation [1]. IkB-z is also upregulated in T cells in response
to stimulation with transforming growth factor (TGF)-b and inter-
leukin (IL)-6 stimulation and positively regulates IL-17A gene
expression in cooperation with RAR-related orphan receptor (ROR)
gt, a master regulator of Th17 cells [2]. Previous studies have shown
that TGF-b stimulation alone was sufﬁcient to induced IkB-z in T
cells, thereby negatively regulating interferon (IFN)-g production
[3]. Thus, deﬁciency of IkB-z in T cells resulted in reduced capacity
for generation of Th17 cells and increased capacity for generation of
IFN-g-producing helper T cells, called Th1 cells.
The balance among T helper cell differentiation determines
many factors, including the balance among the expression of
master regulators and cytokines. Foxp3 is a prominent master
regulator of regulatory T cells (Tregs) and forms a complex withopolysaccharide; TGF, trans-
lated orphan receptor; IFN,
modiﬁed Eagle's medium; PE,
SA, enzyme-linked immuno-
clear factor of kappaB.
4, Japan.
Inc. This is an open access articleRORgt, thereby preventing transcriptional activity and blocking the
differentiation of Th17 cells [4]. On the other hand, RORgt can bind
to the Foxp3 promoter and negatively regulate Treg differentiation
[5]. In addition, Gata3 (a master regulator of Th2 cells) can also bind
to the Foxp3 promoter and negatively regulate Treg differentiation
[6]. Moreover, high levels of IFN-g can inhibit Treg differentiation
and promote Th1 cell differentiation [7], while high levels of IL-4
inhibit Treg differentiation and promote Th2 cell differentiation [8].
Previously, I have shown that IkB-z-deﬁcient T cells have sufﬁ-
cient ability to induce Tregs in response to TGF-b in vitro [3].
However, IkB-z-deﬁcient T cells produce large amounts of IFN-g,
even in the presence of TGF-b. Therefore, in this study, the role of
IkB-z in maintaining the T cell balance was examined further. The
data showed that production of high amounts of inﬂammatory
cytokines from IkB-z-deﬁcient T cells prevented the generation of
Foxp3þ Tregs and that IkB-z itself could control Foxp3 gene
expression.2. Materials and methods
2.1. Mice
C57BL/6 mice were purchased from Charles River Laboratories
Japan, Inc. (Yokohama, Japan). Nfkbizﬂox/ﬂox [9] and Lck-Cre [10]
mice were described previously. All mice were maintained under
speciﬁc pathogen-free conditions in the animal facilities of Tohokuunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Animal Care and Use Committee.2.2. Cells
EL4/LAF lymphoma cells [11] were kindly provided by Dr.
Mathew C. Weber (Thomas Jefferson University) and were cultured
in IMDMplus GlutaMax (Life Technologies Corp., Carlsbad, CA, USA)
supplemented with 5% (v/v) heat-inactivated fetal calf serum,
100 U/mL penicillin, and 100 mg/mL streptomycin. HEK293 cells
were cultured in Dulbecco's modiﬁed Eagle's medium (DMEM;
Wako Pure Chemical Industries, Osaka, Japan) supplemented with
10% (v/v) heat-inactivated fetal calf serum,100 U/mL penicillin, and
100 mg/mL streptomycin. CD4þCD62Lþ T cells were prepared from
spleens using a CD4þCD62Lþ isolation kit II (Miltenyi Biotec, Ber-
gisch Gladbach, Germany) unless otherwise described.
CD4þCD62Lþ T cells were cultured in RPMI1640 (Wako Pure
Chemical Industries) supplemented with 10% (v/v) heat-inactivated
fetal calf serum, 100 U/mL penicillin, and 100 mg/mL streptomycin.2.3. Plasmids, antibodies, and cytokines
Expression vectors for FLAG-tagged mouse IkB-z and p65
(pcDNA3-FLAG-mIkB-z, -mp65) and plasmids for retroviral trans-
duction (pMY-IRES-EGFP and pMY-FLAG-mIkB-z-IRES-EGFP) were
described previously [9]. The pFoxp3-promoter vector was a kind
gift from Dr. Akihiko Yoshimura (Keio University) [12]. pcDNA3 and
phRL-TK were obtained from Life Technologies and Promega Corp.
(Madison, WI, USA), respectively. APC-conjugated anti-IL-17A
(TC11-18H10.1), Paciﬁc Blue-conjugated anti-CD4 (GK1.5), and
phycoerythrin (PE)-conjugated anti-Helios (22F6) antibodies were
purchased from Biolegend, Inc. (San Diego, CA, USA). AntieIFNeg
(XMG1.2) and anti-IL-4 (11B11) antibodies were from eBioscience,
Inc. (San Diego, CA, USA). APC-conjugated anti-Foxp3 (FJK-16S)
antibodies were from BD Biosciences (San Jose, CA, USA). Anti-IkB-z
(C-15) antibodies and normal goal IgG were purchased from Santa
Cruz Biotechnology, Inc. (Dallas, TX, USA). Polyclonal anti-CD3 an-
tibodies used for immunohistochemistry were purchased from
Sigma Aldrich Co. LLC. (St. Louis, MO, USA). Recombinant human
TGF-b1 was obtained from PeproTech, Inc. (Rocky Hill, NJ, USA).2.4. In vitro cell culture
Naïve CD4þ CD62Lþ Tcells were culturedwith plate-bound anti-
CD3 (1 mg/mL) and soluble anti-CD28 (1 mg/mL) antibodies. TGF-b1
(2 ng/mL), antieIFNeg (10 mg/mL), and anti-IL-4 (10 mg/mL) were
used as indicated [13]. For chromatin immunoprecipitation (ChIP)
and western blotting, EL4/LAF cells were stimulated with plate-
bound anti-CD3 (1 mg/mL) and soluble anti-CD28 (1 mg/mL) anti-
bodies with or without TGF-b1 (2 ng/mL).2.5. Retroviral transduction
Recombinant retroviruses were prepared by transfecting Plat-E
packaging cells with the indicated plasmids using the calcium
phosphate-DNA coprecipitation method [14]. Naive CD4þ T cells
(1  106 cells/mL) stimulated with plate-bound anti-CD3 (1 mg/mL)
and soluble anti-CD28 (1 mg/mL) antibodies for 24 h were infected
with fresh retroviral supernatant by centrifugation for 2 h at
780  g in the presence of 10 mg/mL polybrene (SigmaeAldrich).
Cells were further cultured for 2 days with or without TGF-b1 (2 ng/
mL).2.6. Flow cytometric analysis
Cell suspensions were prepared from thymus, spleen, or lymph
nodes by sieving and gentle pipetting. Cell surface antigens were
stained with the indicated antibodies in ice-cold phosphate-buff-
ered saline containing 0.5% bovine serum albumin in the dark at
4 C. Intranuclear staining of Foxp3 and Helios were performed
with a Foxp3 staining buffer kit (eBioscience) according to the
manufacturer's protocol. Stained cells were subjected to ﬂow
cytometric analysis with Gallios (Beckman Coulter, Inc., Brea, CA,
USA). Data were analyzed with FlowJo software (Tree Star, Inc.,
Ashland, OR, USA).
2.7. Luciferase assay
HEK293 cells (1  105 cells) were transfected using the calcium
phosphate-DNA coprecipitation method [14] with an individual
reporter (0.45 mg), pcDNA3 (0.016e0.16 mg), pcDNA3-FLAG-mp65
(0.05 mg), and/or pcDNA3-FLAG-mIkB-z (0.1 mg), and pRL-TK-Luc
(0.001 mg). Twenty-four hours after transfection, the medium was
changed, and the cells were incubated for an additional 24 h.
Luciferase activities were measured by the Dual-Luciferase Re-
porter Assay System according to the manufacturer's instructions
(Promega).
2.8. ChIP assay
EL4/LAF cells were activated with plate-bound anti-CD3 and
soluble anti-CD28 with or without TGF-b1 for 24 h. ChIP was per-
formed by using anti-IkB-z antibodies and normal goat IgG ac-
cording to our previously described methods [15].
Immunoprecipitated and input DNA were then analyzed by quan-
titative polymerase chain reaction (PCR) using SYBR Premix EX Taq
(Takara Bio). The primer sequences were as follows: 50-
TTCCTCCCGCTCTCTGACTCT-30 and 50-AAGCGCCAGTTGTGTACAAA-
TATC-30 for the Foxp3 promoter; 50-GTTTTGTGTTTTAAGTCTTTTG-
CACTTG-30 and 50-CAGTAAATGGAAAAAATGAAGCCATA-30 for the
Foxp3 CNS1; 50-GTTGCCGATGAAGCCCAAT-30 and 50-
ATCTGGGCCCTGTTGTCACA-30 for the Foxp3 CNS2.
2.9. Enzyme-linked immunosorbent assay (ELISA)
ELISA kits for IL-4 (eBioscience) were used to quantify respective
cytokines in the culture supernatants according to the manufac-
turer's protocols.
2.10. Statistical analysis
Student's t-tests (two-tailed) were used to determine signiﬁcant
differences between two groups. Differences with p values of less
than 0.05 were considered signiﬁcant.
3. Results
3.1. IkB-z-deﬁcient T cells produced large amounts of inﬂammatory
cytokines, preventing Treg generation
T cell-speciﬁc IkB-z-deﬁcient mice (Nfkbizf/f Lck-cre; cKO) have
been shown to have increased Foxp3þ Tregs in the periphery [3].
Therefore, to further analyze this effect of IkB-z deﬁciency, the
percentage of HeliosFoxp3þ Tregs (putative peripheral-inducing
Tregs) [16] in the spleens from T cell-speciﬁc IkB-z-deﬁcient mice
(cKO) was examined. Interestingly, the data showed that these
Tregs were present at higher percentages in cKO mice than in
control mice (Fig. 1A and B). However, the ratios of HeliosFoxp3þ
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Fig. 1. Analysis of Helios expression in Tregs in T cell-speciﬁc IkB-z-deﬁcient mice.
(A) Flow cytometric analysis of CD4þ lymphocytes cells in the spleens of 3-week-old
Nfkbizf/f (control) and Nfkbizf/f Lck-Cre (cKO) mice. The data show a representative of
three independent experiments. (B) Percentages of HeliosFoxp3þ in CD4þ cells. (C)
Relative percentages of HeliosFoxp3þ Tregs of total Foxp3þ Tregs. The percentage of
total Foxp3þ Tregs was set to “1”. The horizontal bars represent the mean. *p < 0.05.
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mice (Fig. 1 C). Tregs from cKO mice would then also be expanded,
depending on high levels of IL-2 secretion by CD4þ T cells [3]; thus,
IkB-z deﬁciency in T cells did not prevent peripheral-induction of
Tregs in vivo.
A previous study showed that IkB-z-deﬁcient T cells are gener-
ated in Foxp3þ Tregs in response toTGF-b in vitro [2]. However, IkB-
z-deﬁcient T cells express high levels of IFN-g, even in the presence
of TGF-b [3]. In this study, IL-4 production from control and IkB-z-
deﬁcient T cells was signiﬁcantly reduced in the presence of TGF-b,
and IkB-z-deﬁcient T cells showed high levels of IL-4 production
(Fig. 2A). Because exogenous IFN-g and IL-4 prevent Treg genera-
tion, I hypothesized that autocrine cytokine pathways in IkB-z-
deﬁcient T cells may prevent Foxp3þ Treg differentiation. To test
this hypothesis, puriﬁed naïve CD4þ Tcells cultured in the presence
of TGF-b plus neutralizing antibodies (NABs: antieIFNeg and anti-
IL-4). Interestingly, in the presence of TGF-b and NABs, IkB-z-deﬁ-
cient T cells showed greater induction of Foxp3þ Tregs than that
observed in control T cells (Fig. 2B). These results suggested that
IkB-z-deﬁcient T cells produced large amounts of IFN-g and IL-4,
even in the presence of TGF-b, thereby preventing Foxp3
differentiation.
3.2. IkB-z negatively regulated Foxp3 gene expression
Because IkB-z-deﬁcient T cells had the ability to generate
Foxp3þ Tregs when the cytokine autocrine pathwaywas inhibited, I
next asked whether IkB-z directly controlled Foxp3 gene expres-
sion. To clarify the mechanisms involved in this process, mouse T
cell lymphoma EL-4/LAF cells were used; these cells are known to
upregulate Foxp3 gene expression in response to TGF-b stimulation
[11]. Moreover, IkB-z expression in T cells can be induced by TGF-b
stimulation [3]. The data showed that IkB-z could be upregulated in
response to TGF-b stimulation even in EL-4/LAF cells (Fig. 3A).A
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Fig. 2. IkB-z-deﬁcient T cells cultured in vitro. (A) Enzyme-linked immunosorbent
assay for IL-4 in the supernatants of naïve CD4þ T cells cultured for 72 h. Numbers
indicate the mean ± SD (n ¼ 3). (B) Flow cytometric analysis of Foxp3 expression in
CD4þ T cells from Nfkbizf/f (control) and Nfkbizf/f Lck-Cre (cKO) mice cultured for 24 h in
the presence or absence of TGF-b1 and neutralizing antibodies (NABs: antieIFNeg and
anti-IL-4). Numbers indicate the percentage of Foxp3þ Tregs. The horizontal bars
represent the mean. *p < 0.05, **p < 0.01.The Foxp3 gene has several conserved noncoding sequences (i.e.,
the promoter, CNS1, and CNS2 regions), and these sequences play
important roles in Foxp3 gene expression [17]. To address the role of
IkB-z in Foxp3 gene expression, I performed ChIP assays and found
that IkB-z could bind to the Foxp3 promoter region in the presence
of TGF-b (Fig. 3B).
IkB-z can also form a complexwith nuclear factor of kappaB (NF-
kB) and control NF-kB target gene expression [18]. In addition, the
Foxp3 promoter can be activated by NF-kB [19,20]. Therefore, I next
conﬁrmed that overexpression of the NF-kB p65 subunit could
signiﬁcantly activate Foxp3 promoter activity, but that this function
was negatively regulated by IkB-z (Fig. 4A). In addition, retroviral
overexpression of IkB-z in T cells prevented Foxp3þ Treg induction
in response to TGF-b (Fig. 4B and C). Thus, these results suggested
that IkB-z itself negatively regulated Foxp3 gene expression.4. Discussion
In this study, the role of IkB-z deﬁciency inmaintenance of T-cell
subsets was examined. The data showed that IkB-z had an impor-
tant role in mediating the generation of Foxp3þ Tregs, providing
important insights into the immune cell balance and shifts in T-cell
subsets.
Foxp3, a master regulator of Treg, is well known to control gene
expression. TCR and TGF-b are two signaling molecules that play
crucial roles in the regution of Foxp3 gene expression [17]. The TGF-
b signaling molecule ‘Smad’ ﬁrst binds to the CNS1 region of the
Foxp3 gene [11, 21]. NF-kB enriched on the Foxp3 promoter region
then positively regulates Foxp3 gene expression. In addition, the
transcriptional factor ‘TGF-b-inducible early gene 1’ also plays an
important role in the regulation of Foxp3 gene expression by
binding to the promoter region [22]. All these molecules positively
regulate Foxp3 gene expression. However, it is also important to
prevent or suppress the expression of the negative regulators of
Foxp3 gene expression. Gata3, a Th2 master regulator, is known to
bind to the Foxp3 promoter region and negatively regulates Foxp3
gene expression [6, 13]. It is also known that TGF-b inhibits Gata3
expression [23], thus promoting Foxp3 gene expression. Although
TGF-b plays crucial roles in the promotion of Foxp3 gene expression
[24], TGF-b-induced IkB-z negatively regulates Foxp3 gene
expression.
Exogenous inﬂammatory cytokines also affect Foxp3 gene
expression. Exogenous IFN-g and IL-4 can inhibit Treg differentia-
tion [7, 8]. In addition, the inhibition of IL-17 expression increases
Foxp3 gene expression [25]. Overexpression of IkB-z in T cells is
hard to detect IL-17, even in the presence of TGF-b [2]. On the otherTGF−β      −        +       
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Fig. 4. IkB-z negatively regulated Foxp3 gene expression. (A) Foxp3 reporter activity
in HEK293 cells (mean þ SD, triplicate samples). Data are representative of at least
three experiments. (B) CD4þ T cells were retrovirally transduced to express IkB-z and
green ﬂuorescence protein (GFP). Foxp3þ Tregs were induced with 2 ng/mL of TGF-b1
for 48 h. (C) Relative Treg induction in GFP-positive populations. TGF-b1-induced Tregs
in the GFP-negative population was set as “1” (mean þ SE, n ¼ 3). *p < 0.05, **p < 0.01,
***p < 0.001. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
T. MaruYama / Biochemical and Biophysical Research Communications 464 (2015) 586e589 589hand, overexpression of IkB-z in T cell strongly inhibits IFN-g pro-
duction [3]. Thus, overexpression of IkB-z in T cell prevents Foxp3
gene expression, independent of cytokines autocrine pathways.
Taken together, the ﬁndings in this study indicated that IkB-z
controlled cytokine production and NF-kB-dependent Foxp3 gene
expression, thus participating in the maintenance of the balance
among Th cell subsets.
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